Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: Dave K who wrote (84)	2/15/2000 3:39:00 PM
From: scaram(o)uche	Respond to of 1833

I have no trouble getting in... they have updated the hardware page, and here's the flow description...... HT-PS™/Flow: A fully automated fluidics system that exploits flow cytometry as a detection device. This system will provide extremely high information content, including simultaneous assessment of compound binding affinities, functional activities and potencies with high sensitivity multiplexing capabilities. The single-cell analytical capability of the HT-PS™/Flow system will support complex cellular subset analyses necessary to evaluate 'hit' compound activities on patient cell samples and heterogeneous cultured cell samples.

To: Dave K who wrote (84)	2/15/2000 3:56:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1833

from the '99 10-K...... The injunction does not affect Solvay Pharmaceuticals since it utilizes screening assays obtained from the Company solely outside the United States. A post at Yahoo reminded me of this. I went looking for it, but Miljenko beat me to it. This might mean that, given relocation of the functional genomics effort in Europe, all would avoid "SIBI" if screening was restricted to that geography. I had never assigned value for bringing the business back to life. It's a methods patent. Sheeeesh... another talking head on CNBC right now (Waddel Science Fund, or something like that), spouting "genomics". Why can't they find the leverage? <g>